AN1 — Anagenics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$5.91m
- AU$5.37m
- AU$5.16m
Annual cashflow statement for Anagenics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | C2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.651 | 0.368 | 0.639 | 0.474 | 1.02 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.53 | -1.76 | -1.77 | -1.58 | -1.07 |
| Capital Expenditures | -0.036 | -0.045 | -0.098 | 0 | -0.025 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.932 | -1.46 | -0.1 | 0 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.968 | -1.51 | -0.198 | 0 | -0.025 |
| Financing Cash Flow Items | -0.024 | -0.293 | -0.149 | 0 | -0.151 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.073 | 2.54 | 1.02 | 0.345 | 1.28 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.44 | -0.718 | -0.943 | -1.23 | 0.182 |